Journal List > Korean J Obstet Gynecol > v.55(3) > 1088411

Chung, Park, Park, Kim, Chun, Cho, and Park: Association of genital Mycoplasmas infection in women who had preterm delivery and outcomes in premature infants

Abstract

Objective

We conducted this study to evaluate the relationship between genital Mycoplasmas infection in women who had preterm delivery and the neontal outcomes.

Methods

We studied 116 women with preterm delivery (gestational age, ranged from 24 to 37 weeks) and their 116 premature infants born at Ewha Womans University Mokdong Hospital from August 2009 to December 2010. Culture for genital Mycoplasmas or a polymerase chain reaction was performed in vaginal fluid obtained from women who had preterm delivery. For perinatal outcomes, chorioamnionitis, funisitis and puerperal infection were analysed. We also evaluated the following neonatal data; birth weight, sex, small for gestational age, Apgar score, cord blood pH, ventilator care, hospital days, incidence of respiratory distress syndrome, bronchopulmonary dysplasia, sepsis, intraventricular hemorrhage and patent ductus arteriosus.

Results

Genital Mycoplasmas were isolated in 36.2% (42 of 116 patients). History of prior preterm birth was significantly higher and the cervical length at admission was significantly shorter in patients with genital Mycoplasmas infection (P < 0.05). Perinatal outcomes according to the Mycoplasmas infection and the neonatal outcomes were not statistically different between study and control groups. The relative risk of respiratory distress syndrome and bronchopulmonary dysplasia were 1.55 (95% confidence interval [CI], 0.65-3.70), and 1.24 (95% CI, 0.42-3.67), respectively.

Conclusion

There is higher incidence of prior preterm birth and shorter cervical length in patient with genital Mycoplasmas infection. However, genital Mycoplasmas infection does not affect the neonatal outcomes.

Figures and Tables

Table 1
Mycoplasma hominis and Ureaplasma urealyticum infection
kjog-55-158-i001

M, Mycoplasma hominis ; U, Ureaplasma urealyticum.

Table 2
Clinical characteristics
kjog-55-158-i002

Values are presented as mean ± standard deviation or number (%).

M, Mycoplasma hominis ; U, Ureaplasma urealyticum ; GDM, gestational diabetic mellitus; PROM, premature rupture of membrane.

aThis is the number except primiparity.

bP < 0.05

Table 3
Delivery outcomes according to Mycoplasma hominis and Ureaplasma urealyticum infection
kjog-55-158-i003

Values are presented as number (%).

Table 4
Effect of Mycoplasma hominis and Ureaplasma urealyticum infection on neonatal morbidity
kjog-55-158-i004

Values are presented as mean ± standard deviation or number (%).

CI, confidence interval; SGA, small for gestational age; RDS, respiratory distress syndrome; IVH, intraventricular hemorrhage; BPD, bronchopulmonary dysplasia; PDA, patent ductus arteriosus.

aNon-parametric analysis using Wilcoxon rank-sum test.

References

1. Challis JR, Lye SJ, Gibb W, Whittle W, Patel F, Alfaidy N. Understanding preterm labor. Ann N Y Acad Sci. 2001. 943:225–234.
2. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol. 1988. 31:553–584.
3. Romero R, Shamma F, Avila C, Jimenez C, Callahan R, Nores J, et al. Infection and labor. VI. Prevalence, microbiology, and clinical significance of intraamniotic infection in twin gestations with preterm labor. Am J Obstet Gynecol. 1990. 163:757–761.
4. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000. 183:1124–1129.
5. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol. 1998. 179:186–193.
6. Lamont RF, Duncan SL, Mandal D, Bassett P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol. 2003. 101:516–522.
7. Anagrius C, Loré B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect. 2005. 81:458–462.
8. Kataoka S, Yamada T, Chou K, Nishida R, Morikawa M, Minami M, et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol. 2006. 44:51–55.
9. Cassell GH, Waites KB, Watson HL, Crouse DT, Harasawa R. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev. 1993. 6:69–87.
10. Velemínský M, Tosner J. Relationship of vaginal microflora to PROM, pPROM and the risk of early-onset neonatal sepsis. Neuro Endocrinol Lett. 2008. 29:205–221.
11. Katz B, Patel P, Duffy L, Schelonka RL, Dimmitt RA, Waites KB. Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia. J Clin Microbiol. 2005. 43:4852–4854.
12. Kim MJ, Choi MH, Seong WJ, Koo TB, Park IS. The detection rate of Ureaplasma urealyticum and Mycoplasma hominis in patients with impending preterm birth and mid-trimester cervical swab. Korean J Perinatol. 2008. 19:370–376.
13. Kim SY, Lee YJ, Meen H, Lee SH, Park IY, Ahn HY, et al. Analysis of mycoplasma hominis and ureaplasma urealyticum infection in preterm labor and prom patients. Korean J Obstet Gynecol. 2004. 47:1469–1473.
14. Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, et al. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med. 1996. 334:567–572.
15. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000. 183:S1–S22.
16. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979. 28:1039–1057.
17. WHO Expert Committee on Diabetes Mellitus: second report. World Health Organ Tech Rep Ser. 1980. 646:1–80.
18. Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis. 1982. 145:1–8.
19. Hollander D. Diagnosis of chorioamnionitis. Clin Obstet Gynecol. 1986. 29:816–825.
20. Lubchenco LO, Hansman C, Dressler M, Boyd E. Intrauterine Growth as Estimated from Liveborn Birth-Weight Data at 24 to 42 Weeks of Gestation. Pediatrics. 1963. 32:793–800.
21. Volpe JJ. Neonatal intracranial hemorrhage. Pathophysiology, neuropathology, and clinical features. Clin Perinatol. 1977. 4:77–102.
22. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001. 163:1723–1729.
23. Taylor-Robinson D, McCormack WM. The genital mycoplasmas (first of two parts). N Engl J Med. 1980. 302:1003–1010.
24. Kong F, Ma Z, James G, Gordon S, Gilbert GL. Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays. J Clin Microbiol. 2000. 38:1175–1179.
25. McCormack WM, Rosner B, Lee YH. Colonization with genital mycoplasmas in women. Am J Epidemiol. 1973. 97:240–245.
26. Chang MW, Choi TK, Yoshii Z, Matsuo Y. Isolation of Ureaplasma urealyticum and Mycoplasma hominis from patients with genitourinary tract infection. Hiroshima J Med Sci. 1984. 33:53–56.
27. Mårdh PA, Weström L. T-mycoplasmas in the genito-urinary tract of the female. Acta Pathol Microbiol Scand B Microbiol Immunol. 1970. 78:269.
28. Klein JO, Buckland D, Finland M. Colonization of newborn infants by mycoplasmas. N Engl J Med. 1969. 280:1025–1030.
29. Braun P, Lee YH, Klein JO, Marcy SM, Klein TA, Charles D, et al. Birth weight and genital mycoplasmas in pregnancy. N Engl J Med. 1971. 284:167–171.
30. Embree JE, Krause VW, Embil JA, MacDonald S. Placental infection with Mycoplasma homonis and Ureaplasma urealyticum: clinical correlation. Obstet Gynecol. 1980. 56:475–481.
31. Yoon BH, Romero R, Lim JH, Shim SS, Hong JS, Shim JY, et al. The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol. 2003. 189:919–924.
32. Hannaford K, Todd DA, Jeffery H, John E, Blyth K, Gilbert GL. Role of ureaplasma urealyticum in lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed. 1999. 81:F162–F167.
33. Cultrera R, Seraceni S, Germani R, Contini C. Molecular evidence of Ureaplasma urealyticum and Ureaplasma parvum colonization in preterm infants during respiratory distress syndrome. BMC Infect Dis. 2006. 6:166.
34. Benstein BD, Crouse DT, Shanklin DR, Ourth DD. Ureaplasma in lung. 2. Association with bronchopulmonary dysplasia in premature newborns. Exp Mol Pathol. 2003. 75:171–177.
35. Colaizy TT, Morris CD, Lapidus J, Sklar RS, Pillers DA. Detection of ureaplasma DNA in endotracheal samples is associated with bronchopulmonary dysplasia after adjustment for multiple risk factors. Pediatr Res. 2007. 61:578–583.
36. Walsh WF, Butler J, Coalson J, Hensley D, Cassell GH, deLemos RA. A primate model of Ureaplasma urealyticum infection in the premature infant with hyaline membrane disease. Clin Infect Dis. 1993. 17:Suppl 1. S158–S162.
37. Patterson AM, Taciak V, Lovchik J, Fox RE, Campbell AB, Viscardi RM. Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants. Pediatr Infect Dis J. 1998. 17:321–328.
38. Ollikainen J, Korppi M, Heiskanen-Kosma T, Heinonen K. Chronic lung disease of the newborn is not associated with Ureaplasma urealyticum. Pediatr Pulmonol. 2001. 32:303–307.
39. Cassell GH, Davis RO, Waites KB, Brown MB, Marriott PA, Stagno S, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis. 1983. 10:294–302.
40. Cassell GH, Waites KB, Crouse DT, Rudd PT, Canupp KC, Stagno S, et al. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet. 1988. 2:240–245.
TOOLS
Similar articles